Annual Accounts Payable
$11.45 M
+$1.06 M+10.17%
31 December 2023
Summary:
Intra-Cellular Therapies annual accounts payable is currently $11.45 million, with the most recent change of +$1.06 million (+10.17%) on 31 December 2023. During the last 3 years, it has risen by +$5.95 million (+108.15%). ITCI annual accounts payable is now -17.97% below its all-time high of $13.96 million, reached on 31 December 2018.ITCI Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$10.34 M
-$7.21 M-41.09%
30 September 2024
Summary:
Intra-Cellular Therapies quarterly accounts payable is currently $10.34 million, with the most recent change of -$7.21 million (-41.09%) on 30 September 2024. Over the past year, it has dropped by -$275.00 thousand (-2.59%). ITCI quarterly accounts payable is now -41.09% below its all-time high of $17.55 million, reached on 30 June 2024.ITCI Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.2% | -2.6% |
| 3 y3 years | +108.2% | -14.1% |
| 5 y5 years | -18.0% | +65.9% |
ITCI Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +108.2% | -41.1% | +33.7% |
| 5 y | 5 years | -18.0% | +108.2% | -41.1% | +88.9% |
| alltime | all time | -18.0% | +601.3% | -41.1% | +2386.3% |
Intra-Cellular Therapies Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $10.34 M(-41.1%) |
| June 2024 | - | $17.55 M(+52.2%) |
| Mar 2024 | - | $11.53 M(+0.7%) |
| Dec 2023 | $11.45 M(+10.2%) | $11.45 M(+7.9%) |
| Sept 2023 | - | $10.61 M(+37.2%) |
| June 2023 | - | $7.73 M(-8.4%) |
| Mar 2023 | - | $8.44 M(-18.8%) |
| Dec 2022 | $10.39 M(+19.6%) | $10.39 M(-26.9%) |
| Sept 2022 | - | $14.22 M(+32.3%) |
| June 2022 | - | $10.75 M(-7.7%) |
| Mar 2022 | - | $11.65 M(+34.0%) |
| Dec 2021 | $8.69 M(+58.0%) | $8.69 M(-27.8%) |
| Sept 2021 | - | $12.03 M(-24.5%) |
| June 2021 | - | $15.94 M(+82.8%) |
| Mar 2021 | - | $8.72 M(+58.5%) |
| Dec 2020 | $5.50 M(-25.9%) | $5.50 M(-35.8%) |
| Sept 2020 | - | $8.57 M(+56.6%) |
| June 2020 | - | $5.47 M(-50.2%) |
| Mar 2020 | - | $10.99 M(+48.1%) |
| Dec 2019 | $7.42 M | $7.42 M(+19.2%) |
| Sept 2019 | - | $6.23 M(+10.6%) |
| June 2019 | - | $5.63 M(-34.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $8.57 M(-38.6%) |
| Dec 2018 | $13.96 M(+126.1%) | $13.96 M(+33.6%) |
| Sept 2018 | - | $10.45 M(+94.3%) |
| June 2018 | - | $5.38 M(-46.4%) |
| Mar 2018 | - | $10.04 M(+62.6%) |
| Dec 2017 | $6.17 M(+64.4%) | $6.17 M(+40.1%) |
| Sept 2017 | - | $4.41 M(+148.3%) |
| June 2017 | - | $1.78 M(-75.2%) |
| Mar 2017 | - | $7.16 M(+90.6%) |
| Dec 2016 | $3.75 M(+129.9%) | $3.75 M(-30.7%) |
| Sept 2016 | - | $5.42 M(+39.3%) |
| June 2016 | - | $3.89 M(+98.5%) |
| Mar 2016 | - | $1.96 M(+20.0%) |
| Dec 2015 | $1.63 M(-20.5%) | $1.63 M(+131.6%) |
| Sept 2015 | - | $705.00 K(-85.6%) |
| June 2015 | - | $4.91 M(+7.4%) |
| Mar 2015 | - | $4.57 M(+122.8%) |
| Dec 2014 | $2.05 M(-39.5%) | $2.05 M(+307.4%) |
| Sept 2014 | - | $503.90 K(+21.2%) |
| June 2014 | - | $415.80 K(-80.6%) |
| Mar 2014 | - | $2.14 M(-36.9%) |
| Dec 2013 | $3.40 M | $3.40 M(-15.7%) |
| Sept 2013 | - | $4.03 M |
FAQ
- What is Intra-Cellular Therapies annual accounts payable?
- What is the all time high annual accounts payable for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual accounts payable year-on-year change?
- What is Intra-Cellular Therapies quarterly accounts payable?
- What is the all time high quarterly accounts payable for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly accounts payable year-on-year change?
What is Intra-Cellular Therapies annual accounts payable?
The current annual accounts payable of ITCI is $11.45 M
What is the all time high annual accounts payable for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual accounts payable is $13.96 M
What is Intra-Cellular Therapies annual accounts payable year-on-year change?
Over the past year, ITCI annual accounts payable has changed by +$1.06 M (+10.17%)
What is Intra-Cellular Therapies quarterly accounts payable?
The current quarterly accounts payable of ITCI is $10.34 M
What is the all time high quarterly accounts payable for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly accounts payable is $17.55 M
What is Intra-Cellular Therapies quarterly accounts payable year-on-year change?
Over the past year, ITCI quarterly accounts payable has changed by -$275.00 K (-2.59%)